Supply Chain
Stryker aims to support value-based care with its Cobra reusable suture passer for arthroscopic rotator cuff repair. Here are three insights.
DePuy Synthes launched its Attune Revision Knee System in the U.S.
BostonSight appointed Daniel C. Brooks, MD, as its full-time CMO.
Medial EarlySign closed a $30 million series B financing round, bringing its funding total to $50 million.
Takeda will construct a $30.82 million (€25 million) modular cell therapy facility in Dublin, Ireland, BioSpectrum reports.
Flex designed a platform for storing and analyzing medical device information on Google Cloud, according to Medical Plastics News. Here are four insights.
The FDA issued a Class I recall — the most serious recall classification — for some of Medtronic's cardiac resynchronization therapy and implantable cardioverter defibrillators. Here are four things to know.
Mylan and Revance Therapeutics announced plans to develop and commercialize a biosimilar to Allergan's Botox, TheStreet reports.
Eli Lilly conducted human trials of a drug to treat osteoarthritis pain, which found the drug lacked efficacy. Researchers at the Linda and Jack Gill Center for Biomolecular Science at Indiana University in Bloomington, however, have found the compound blocks…
On Feb. 26, Boston Scientific completed a $1 billion public offering of 4 percent interest rate senior notes due March 1, 2028.